Federal grants to Greenstone Biosciences, Inc.
Greenstone Biosciences, Inc. in Palo Alto, California received $4.9 million in federal grants from fiscal 2021 to 2025, across 5 awards. Its largest program was Military Medical Research and Development, with $1.8 million. In fiscal 2025 it was awarded $192,500.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$4.9 million
- Awards5
- Awarded in FY 2025$192,500
- Largest award$1.4 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 0 | $0 |
| FY 2022 | 0 | $0 |
| FY 2023 | 1 | $1.3 million |
| FY 2024 | 4 | $3.4 million |
| FY 2025 | 1 | $192,500 |
Programs that fund Greenstone Biosciences, Inc.
| Program | Awards | Amount |
|---|---|---|
| Military Medical Research and Development | 2 | $1.8 million |
| Cardiovascular Diseases Research | 1 | $1.4 million |
| Biomedical Research and Research Training | 1 | $1.3 million |
| National Center for Advancing Translational Sciences | 1 | $302,500 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 3 | $3.0 million |
| Department of Defense | 2 | $1.8 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Ethnically diverse ipsc-cardiomyocyte panel for pharmacogenomics and drug safety testing - project summary cardiotoxicity is a leading cause of early and late-stage drug attrition during pharmaceutical development. The fda now mandates that all new drugs be tested for cardiotoxicity before entering | Cardiovascular Diseases Research | August 5, 2024 | $1.4 million |
| Elucidating mechanistic pathways of lmna cardiomyopathy and novel therapeutic compounds | Military Medical Research and Development | May 2, 2024 | $1.3 million |
| Ethnically diverse ipsc-cardiomyocyte panel for pharmacogenomics and drug safety testing - project summary cardiotoxicity is a leading cause of early and late-stage drug attrition during pharmaceutical development. The fda now mandates that all new drugs be tested for cardiotoxicity before entering | Biomedical Research and Research Training | September 5, 2023 | $1.3 million |
| Drug discovery for duchenne muscular dystrophy using ai/ml and ipsc-derived organoids | Military Medical Research and Development | July 31, 2024 | $490,000 |
| Ai/ml and ipsc-derived organoids for myotonic dystrophy drug discovery - project summary/abstract drug discovery for rare diseases is often limited by the lack of relevant preclinical models that adequately capture the complexity and diversity of patients affected. Furthermore, clinical trials are b | National Center for Advancing Translational Sciences | May 30, 2024 | $302,500 |
Questions people ask
How much federal grant money does Greenstone Biosciences, Inc. get?
$4.9 million in 5 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Greenstone Biosciences, Inc. the most?
The Department of Health and Human Services, with $3.0 million in 3 awards. The Department of Defense follow.
What is Greenstone Biosciences, Inc.'s largest federal grant?
$1.4 million under Cardiovascular Diseases Research, with its first action in the period on August 5, 2024. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Greenstone Biosciences, Inc.?
Its largest are Military Medical Research and Development, Cardiovascular Diseases Research and Biomedical Research and Research Training.
Other grant recipients in Palo Alto
- Electric Power Research Institute Inc
- Palo Alto Veterans Institute for Research
- City of Palo Alto
- Lucile Salter Packard Childrens Hospital at Stanford
- Beneficent Technology, Inc
- South County Community Health Center, Inc.
- Furno Materials Inc
- Palo Alto Research Center LLC
Largest federal grant recipients in California · Federal grants in California